Welcome Guest from United States
Sign In Change Country
  2 Items   Total 2,864.00 USD
Search:
 Resources
 
Downloadable Files :
 
  Related Products >
  Related Markets >
  App. Note 440: FAIMS Removes Interference in a Validated Small Molecule Bioanalytical Assay
 The goal of this note is to show the removal of an interfering peak due to a concomitantly administered medication using FAIMS.
 

Conclusions FAIMS successfully prevented the ketamine co-med interference from adversely affecting the accuracy and precision of the bioanalytical method. This technology is simple to optimize and the analysis yielded increased signal by 4.5 times and the signal to noise ratio increased by 2000 fold relative to data acquired without FAIMS. Additionally, FAIMS reduced chemical background. This is a robust technique requiring little intervention as demonstrated in this GLP validated assay.

To read/download the complete note, please use the link on this page.

   Products used for this Application
  Product #   Product Name   Image  
 IQLAAEGABBFACEMAFO  FAIMS Interface      Select
 
   Related Markets

  Name
  Clinical Research and Toxicology